Member Info for Laura2022

Are those from today neuncle

So much pain and suffering in the world and yet people spend their time doing this rather than doing good ...

Hope they are at peace

Newincle

That merck poster was significant as PYC took a main podium

Shows the very strong relationship with Merck and PYC

Seems that some want to save people from AIM

You wonder why they don't post on AMTE (£2.00 to bust this weel) VRS £1.00 to utter oblivion RNS today and where CEO was on £400k+ and awarded himself pay rises eevry year apparently

Or RRR KEFI etc that just keep churning the same nonsense

Morning King H

Not checked today as I'm travelling but I woukd imagine there is not much stock available after 1 or 2 buys?

I just wonder if we will get news this week or the half week next week

It looks like it's a concerted effort from the market makers to try to detede.rhe and this during August before the rise from 0.95p to 3p !!

Are you purchasing Newuncle if that's not too rude of me

You're right about the volume but thaylt can change ..in September I think it was trading over 5mln a day

Ab201

It's a quiet weeek across lots of share before festive

Summary of PYC below if that helps

KG

They HAVE talked about VAL 201 including 44th minute onwards on Mondays Q and A

Hope that helps

As we saw yesterday...one £5k buy changed the asking price

Imagine of them together

Yes newuncle

This point was re iterated a few weeks ago

£2mln with cash and cash equivalent qt date of annual report of c£700k since the n4new contracts and a net gain funding project òf £136k ( as the staffing costs are already on the company books) and q potential £1mln pipeline

Buyers are getting a bargain at 1.6p

Chancellor Jeremy Hunt says that the UK is "back on the path to healthy, sustainable growth" after the rate of inflation fell to 3.9% in November.

The government had set a target of halving inflation in 2023. Hunt says that "with inflation more than halved, we are starting to remove inflationary pressures from the economy. We are back on the path to healthy, sustainable growth."

It was apparently £1.00 when the old CEO was selling his shares

Not sure if that's true ?

Good  slide fron Peter which broke down the 36 project into various sections and that pipeline was £1mln and can be a "top up process" into this pot. The current cash of over £700,000 is good for the foreseeable future and not less than 12-15mths  He said there are 9 of these which are ready to be signed. He re iterated the information from the annual report that they are targeting their best ever revenues (£1.0mln+ ) having already secured about £300k since June 2023 and with Merck back on board in August 2023 whom accounted for 40% of previous revenues (therefore about £300-400k) He expects that Merck will continue be a key client for PYC going forward 

Also stated they would inform the market if these were to be beaten .

A) pipeline of potential new contracts that could start in the current financial year which remains at over £1m despite four opportunities having been converted into signed projects during August

B)We provide a responsive and dedicated service. Many large companies offer services in the cancer space though do not restrict themselves to cancer nor to quantitative pharmacology. As a result, we believe, many of these companies cannot offer the same level of bespoke, responsive service that Physiomics can and does.

C)The Company continues to work in the immuno-oncology space with several of its clients, and it is anticipated that the industry focus on this treatment approach is likely to continue for some time

D PYC  have gained  valuable insight from their work with DoseMeRx, including the adaptation of their dosing tech to now not need in hospital blood tests

I was reading about the old CEO

Totally disgusting

Good news from IQAI yesterday and POLB today

See below

The global interest in AI-led drug discovery continues to grow, with major pharmaceutical players making substantial investments in the field. Poolbeg's RSV AI programme identified these drug treatment candidates in just 10 months. AI-led drug discovery can accelerate the timeline achievable which reduces costs while also decreasing risks and providing a higher likelihood of success in bringing groundbreaking therapies to patients.

Yes Trench

3 Also new office was to aid remote working,

Jim says should save £30k-40k per annum and will be reviewed

4 Also interesting was that he and now Pete mention Project Optimus/FDA modelling expectations in everyclient discussion

This one savings pays for Peter Sargent

Win win

By my calculations they've spent over £100mln and had 2 name changes and 2 100:1 consolidations

Please stay there

Sienna

What have CRCL ( previously RGM ) done for 20yrs ?

Well done everyone

The FDA seem to be fast tracking a few A.I / medical entities

They call it project optimus

IQAI and PYC are the only 2 A.I stocks where A.I approval in America is likely

IQAI one slight step ahead

Well done

Any ideas what they might be referring to please ?